# clm_03E4A3140826

subject: Vertex Pharmaceuticals (/record/vertex-pharmaceuticals.md)  
predicate: quarterly_research_and_development  
value: 223,858,000 United States dollar  
valid_from: 2015-06-30  
valid_to: 2015-09-30  
published: 2015-08-04  
recorded: 2026-11-08  
confidence: 0.95  
status: superseded  
assertable: true  
superseded_by: clm_6E79D9B514B1  
last_updated: 2026-11-08  
cite: AsOf. "Vertex Pharmaceuticals quarterly research and development: 223,858,000 United States dollar", as of 2015-06-30 (until 2015-09-30). Claim clm_03E4A3140826, https://asof.is/claim/clm_03E4A3140826, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/875320/000087532015000047/0000875320-15-000047-index.htm.  
checked: 2026-11-08 · parsed from the SEC filing  
parsed from: us-gaap:ResearchAndDevelopmentExpense in 10-Q Q2 FY2015, filed 2015-08-04  

## Sources

- https://www.sec.gov/Archives/edgar/data/875320/000087532015000047/0000875320-15-000047-index.htm (primary, SEC EDGAR 10-Q Q2 FY2015, published 2015-08-04)

## Supersedes

- [Vertex Pharmaceuticals](/record/vertex-pharmaceuticals.md) | quarterly_research_and_development | 215,599,000 United States dollar | valid 2015-03-31 to 2015-06-30 | conf 0.95 | superseded | superseded_by [clm_03E4A3140826](/claim/clm_03E4A3140826.md) | [clm_2A57AC8A186B](/claim/clm_2A57AC8A186B.md)

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.